Evaluation of metered dose inhaler (MDI) formulations of ciclosporin

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 1, 2007, Pages 15-21

  Marijani, Rukia ^a   Shaik, Madhu Sudhan ^a,b   Chatterjee, Abhijit ^a   Singh, Mandip ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b Barr Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYCLOSPORIN A; FLUORINATED HYDROCARBON; INTERLEUKIN 2; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG ACTIVITY; DRUG FORMULATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; METERED DOSE INHALER;

AEROSOL PROPELLANTS; CYCLOSPORINE; DRUG STABILITY; HUMANS; HYDROCARBONS, FLUORINATED; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; JURKAT CELLS; METERED DOSE INHALERS; PARTICLE SIZE;

EID: 33846365332     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.1.0003     Document Type: Article

References (21)

1. Blot, F., Tavakoli, R., Sellam, S., Epardeau, B., Faurisson, F., Bernard N., Bacquemin, M. N., Frachon, I., Stern, M., Pocidalo, J. J., Carbon, C., Bisson, A., Caubarter, I. (1995) Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histology study. J. Heart Lung Transplant. 14: 1162-1171
2. Burckart, J., Smaldone, G. C., Eldon, M. A., Venkataramanan, R., Dauber, J., Zeevi A., McCurry, K., Mckaveney, T. P., Corcoran, T. E., Griffith, B. P., Iacono, A. T. (2003) Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients. Pharm. Res. 20: 252-256
3. Corcoran, T. E., Smaldone, G. C., Dauber, J. H., Smith, D. A., McCurry, K. R., Burckart, G. J., Zeevi, A., Griffith, B. P., Iacono, A. T. (2004) Preservation of post-transplant lung function with aerosol cyclosporin. Eur. Respir. J. 23: 378-383
4. Freed, B. M., Stevens, C., Brooks, C., Cramer, S., Lempert, N., Rosano, T. G. (1991) Assessment of the biological activity of cylosporine metabolites using the human JURKAT cell line. Trans. Proc. 23: 980-981
5. Griffith B. P., Hardesty, R. L., Armitage, J. M., Hattler, B. G., Pham, S. M., Keenan, R. J., Paradis, I. (1993) A decade of lung transplantation. Ann. Surg. 218: 3210-3220
6. Haynes, A., Shaik, M. S., Chatterjee, A., Singh, M. (2003) Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small-cell lung cancer cell line. Pharm. Res. 20: 1485-1495
7. Heidecke, C.-D., Nicolaus, C., Stadler, J., Adolf, J., Florack, G., Bollschweiler, E., Hoelscher, M. (1988) Biologic assessment of cyclosporine in serum of kidney transplant patients. Transplant. Proc. 20: 294-498
8. Iacono, A. T., Johnson, B. A., Grgurich, W. F., Youssef, J. G., Corcoran, T. E., Seiler, D. A., Dauber, J. H., Smaldone, G. C., Zeevi, A., Yousem, S. A., Fung, J. J., Burckart, G. J., Griffith, B. P. (2006) A randomized trial of inhaled cyclosporine in lung-transplant recipients. N. Engl. J. Med. 354: 141-150
9. Keller, M. (1999) Innovations and perspective of metered dose inhalers in pulmonary drug delivery. Int. J. Pharm. 186: 81-90
10. Koshkina, N. V., Golunski, E., Roberts, L. E., Gilbert, B. E., Knight, V. (2004) Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. J. Aerosol Med. 17: 7-14
11. Leach, C. L., Davidson, P. J., Hasselquist, B. E., Boudreau, R. J. (2002) Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 122: 510-516
12. McAllister, S. M., Alpar, H. O., Teitelbaum, Z., Bennettt, D. B. (1996) Do interactions with phospholipids contribute to the prolonged retention of polypeptides within the lung? Adv. Drug Deliv. Rev. 19: 89-110
13. Mitruka S. N., Alvina, W., McCurry, K. R., Zeevi, A., Mckaveney, T., Venkataramanan, R., Iacono, A., Griffith, B. P., Burckart, G. J. (2000) In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine. J. Heart Lung Transplant. 19: 969-975
14. Mukerjee, N., McGinnis, K., Gnergy, M., Wang, K. K. W. (2001) Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation. Biomed. Biophys. Res. Commun. 285: 1192-1199
15. Myrdal, P. B., Karlage, K., Brown, B., Stein, S. W., Haynes, A. (2004) Optimized dose delivery of the peptide cyclosporine using hydrofluroalkane-based metered dose inhalers. J. Pharm. Sci. 93: 1-8
16. Paradis I., Yousem, S. A., Griffith, B. P. (1993) Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med. 14: 750-763
17. Rohatagi, S., Harding, N., Ozoux, M.-L., Bouriout, J.-P., Kirkeselli, S. L., DeLeij, L., Jensen, B. K. (2000) Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporine A (AD1628) after single and repeated administration in healthy male and female subjects and asthmatic patients. J. Clin. Pharmacol. 40: 1211-1226
18. Shaik, M. S., Haynes, A., McSeen, J., Ikediobi, O., Kanikkannan, N., Singh, M. (2002) Inhalation delivery of anti cancer agents via HFA based metered dose inhaler using methotrexate as a model drug. J. Aerosol Med. 15: 261-270
19. Stein, C. M., Murray, J. J., Wood, A. J. J. (1999) Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect. Clin. Chem. 45: 1477-1484
20. Trulock, E. P. (1993) Management of lung transplant rejection. Chest 103: 1566-1576
21. Xie, Q.-M., Chen, J.-Q., Shen, W.-H., Yang, Q.-H., Bian, R.-L. (2002) Effect of cyclosporine A by aerosol on airway hyperresponsiveness and inflammation in guinea pigs. Acta Pharmacol. Sin. 23: 243-247